New hope for tough breast cancer: experimental drug trial seeks to slow disease progression
Disease control
Not yet recruiting
This study is testing whether the drug sacituzumab govitecan can slow cancer progression when used as the first treatment for advanced triple-negative breast cancer. Researchers will enroll 24 adults who haven't received prior treatment for their advanced cancer and give them the…
Phase: PHASE2 • Sponsor: Nathalie Levasseur • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC